Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SHANGHAI PECHEM
00338
CN Stock MarketDetailed Quotes
Chengdu Kanghua Biological Products (300841)
- 57.53
- +0.21+0.37%
Trading Apr 28 09:56 CST
7.48BMarket Cap33.01P/E (TTM)
58.28High57.06Low5.05KlotVolume57.33Open57.32Prev Close29.22MTurnover0.43%Turnover Ratio34.00P/E (Static)129.95MShares94.3052wk High2.10P/B6.84BFloat Cap49.4752wk Low68.78Limit Up118.92MShs Float438.90Historical High45.86Limit Down2.13%Range %32.54Historical Low1.00Dividend TTM57.87Avg Price2.41KlotAsk1.74%Div Yield TTM100Lot Size2.03KlotBid
Chengdu Kanghua Biological Products (300841) Balance Sheet
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -44.92%513.32M | 14.95%1.15B | 23.72%943.13M | 12.07%863.01M | -7.53%931.95M | -3.66%1B | 1.58%762.34M | 19.06%770.07M | 58.78%1.01B | 59.54%1.04B |
| Transactional financial assets | --541.83M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --50M | ---- |
| Notes receivable and accounts receivable | -1.50%1.19B | -5.65%1.23B | -5.62%1.32B | -11.64%1.26B | -11.01%1.21B | -7.91%1.3B | 5.78%1.39B | 7.96%1.43B | 4.24%1.36B | 9.59%1.41B |
| -Notes receivable | ---- | ---- | ---- | ---- | ---- | ---- | --700K | ---- | ---- | ---- |
| -Accounts receivable | -1.50%1.19B | -5.65%1.23B | -5.57%1.32B | -11.64%1.26B | -11.01%1.21B | -7.91%1.3B | 5.72%1.39B | 7.96%1.43B | 4.24%1.36B | 9.59%1.41B |
| Other receivables (including interest and dividends) | 1,311.13%21.31M | -62.19%293.18K | -89.60%1.38M | -89.43%1.4M | -91.09%1.51M | -95.27%775.47K | -24.20%13.29M | -23.45%13.26M | -8.53%16.95M | -7.57%16.38M |
| -Other receivable | ---- | -62.19%293.18K | ---- | -89.43%1.4M | ---- | -95.27%775.47K | ---- | -23.45%13.26M | ---- | -7.57%16.38M |
| Advance payment | -1.57%11.68M | -59.16%4.06M | -21.76%8.27M | -44.77%7.36M | -37.26%11.87M | -41.87%9.94M | -52.94%10.57M | -54.96%13.32M | -38.99%18.91M | -51.43%17.09M |
| Inventories | -19.87%150.71M | -20.40%140.81M | -18.32%147.38M | -7.52%179.2M | -0.54%188.08M | 1.93%176.88M | -2.02%180.44M | 1.34%193.76M | 2.02%189.11M | 12.95%173.54M |
| Other current assets | -82.23%1.62M | 634.36%1.47M | --323.01K | --154K | --9.09M | --200.76K | ---- | ---- | ---- | ---- |
| Total current assets | 3.39%2.43B | 1.41%2.52B | 2.35%2.42B | -4.37%2.31B | -10.97%2.35B | -6.36%2.49B | 2.97%2.36B | 9.55%2.42B | 21.54%2.64B | 23.86%2.66B |
| Non Current assets | ||||||||||
| Other non-current financial assets | -2.92%398.14M | -2.90%398.14M | -12.04%406.16M | -11.66%411.92M | -13.00%410.13M | -12.92%410.03M | -11.19%461.75M | -11.08%466.29M | -8.56%471.39M | -6.29%470.87M |
| Long-term equity investment | -1.15%6.28M | -1.15%6.28M | -2.26%6.35M | -2.26%6.35M | -2.26%6.35M | -2.26%6.35M | --6.5M | --6.5M | --6.5M | --6.5M |
| Fixed assets | ---- | -7.94%880M | ---- | 11.30%919.28M | ---- | 12.59%955.91M | ---- | 64.62%825.97M | ---- | 83.91%849.04M |
| Constru in process | ---- | ---- | ---- | ---- | ---- | -97.29%3.04M | ---- | -74.48%119.38M | ---- | -78.55%112.25M |
| Intangible assets | -10.33%14.8M | -10.29%15.71M | 0.37%15.89M | 0.35%15.83M | 7.35%16.5M | 13.91%17.51M | -1.21%15.83M | -2.88%15.78M | -11.18%15.37M | -10.78%15.38M |
| Long deferred expense | 22.46%184.95M | 24.27%177.11M | 34.80%184.7M | 38.51%162.63M | 41.14%151.03M | 50.99%142.52M | 9.65%137.02M | 57.14%117.42M | 96.52%107.01M | 75.58%94.39M |
| Deferred tax assets | 216.49%7.49M | 230.56%6.85M | 689.99%4.15M | 150.62%3.13M | --2.37M | --2.07M | --525.07K | --1.25M | ---- | ---- |
| Other non current assets | 8.15%2.3M | 15.56%2.48M | -57.21%1.71M | -54.82%2.96M | -71.42%2.13M | -45.56%2.15M | -48.87%3.99M | -40.01%6.56M | -2.03%7.45M | -44.08%3.94M |
| Total non current assets | -3.73%1.47B | -3.44%1.49B | -4.33%1.52B | -2.37%1.52B | -1.79%1.53B | -0.82%1.54B | -2.00%1.59B | -2.31%1.56B | -1.10%1.56B | -0.87%1.55B |
| Total assets | 0.58%3.91B | -0.44%4.01B | -0.34%3.94B | -3.59%3.84B | -7.57%3.88B | -4.32%4.03B | 0.91%3.95B | 4.58%3.98B | 12.03%4.2B | 13.42%4.21B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -81.34%30.11M | -25.14%139.9M | -30.75%149.88M | -14.22%151.31M | -23.25%161.32M | -2.11%186.89M | 71.95%216.43M | 27.03%176.4M | 71.80%210.19M | 74.68%190.91M |
| Notes payable and accounts payable | 54.45%12.13M | -49.99%2.95M | -67.86%1.98M | -19.86%4.98M | -30.31%7.85M | -17.20%5.9M | -82.81%6.15M | -87.54%6.22M | -70.26%11.27M | -79.12%7.13M |
| -Notes payable | -15.75%789.9K | ---- | ---- | --937.62K | --937.62K | -76.56%937.62K | -96.19%937.62K | ---- | ---- | -77.53%4M |
| -Accounts payable | 63.97%11.34M | -40.55%2.95M | -62.08%1.98M | -34.94%4.05M | -38.63%6.92M | 58.69%4.97M | -53.37%5.21M | -49.00%6.22M | -28.82%11.27M | -80.85%3.13M |
| Contract liabilities | -57.15%423.36K | -49.45%505.87K | 316.32%439.66K | 121.05%458.4K | 435.47%988.01K | 238.65%1M | -68.49%105.61K | -41.76%207.37K | 118.31%184.51K | 26.29%295.51K |
| Salaries payable | 49.25%15.82M | -21.62%26.15M | 10.84%22.85M | -28.51%12.44M | -26.23%10.6M | -4.51%33.37M | -20.13%20.62M | 21.23%17.4M | 37.39%14.37M | 23.47%34.94M |
| Taxs payable | 861.15%29.93M | 169.04%30.58M | 92.62%22.68M | -62.59%8.41M | -81.83%3.11M | -73.08%11.37M | -28.05%11.78M | 16.47%22.47M | 6.43%17.14M | 81.75%42.22M |
| Other payable (including interest and dividends) | -0.97%220.08M | -27.03%239.22M | -6.89%215.03M | -28.82%218.2M | -33.74%222.23M | -19.30%327.81M | -24.81%230.95M | 2.12%306.56M | -6.03%335.36M | -2.16%406.22M |
| -Dividend payable | ---- | ---- | ---- | ---- | ---- | --2.8M | ---- | ---- | ---- | ---- |
| -Other payable | ---- | -26.40%239.22M | ---- | -28.82%218.2M | ---- | -19.99%325.01M | ---- | 2.12%306.56M | ---- | -2.16%406.22M |
| Other current liabilities | 83.35%54.35K | -53.17%14.06K | 316.32%13.19K | 121.05%13.75K | 435.47%29.64K | 238.65%30.02K | -68.49%3.17K | 17.79%6.22K | 114.34%5.54K | 26.29%8.87K |
| Total current liabilities | -24.03%308.55M | -22.43%439.32M | -15.05%412.88M | -25.21%395.82M | -30.99%406.14M | -16.92%566.37M | -5.13%486.03M | 1.01%529.26M | 8.00%588.53M | 11.45%681.72M |
| Current liabilities | ||||||||||
| Estimate liabilities | 696.89%25.08M | 230.07%24.88M | 151.33%9.57M | -6.41%3.02M | -21.80%3.15M | 57.29%7.54M | 5.50%3.81M | 0.18%3.22M | 18.34%4.02M | 20.33%4.79M |
| Deferred tax liabilities | --16.15K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -61.01%1.9M | -36.86%2.5M |
| Long term deferred income | 27.35%7.85M | 31.55%8.11M | 35.75%8.37M | -3.16%5.99M | -0.49%6.17M | -0.53%6.17M | 7,198.92%6.17M | --6.18M | --6.2M | --6.2M |
| Total non current liabilities | 253.75%32.95M | 140.74%32.99M | 79.88%17.94M | -4.27%9M | -23.15%9.31M | 1.58%13.7M | -58.17%9.98M | -59.85%9.4M | -49.54%12.12M | -43.05%13.49M |
| Total liabilities | -17.80%341.49M | -18.58%472.31M | -13.14%430.82M | -24.85%404.82M | -30.83%415.45M | -16.56%580.07M | -7.49%496.01M | -1.59%538.67M | 5.57%600.65M | 9.41%695.22M |
| Shareholders equity | ||||||||||
| Paid-in capital | -2.26%129.95M | -2.26%129.95M | -3.49%129.95M | -1.27%132.95M | -1.27%132.95M | -1.27%132.95M | 0.00%134.65M | 0.00%134.65M | 0.00%134.65M | 0.00%134.65M |
| Capital reserve funds | -20.45%861.15M | -20.45%861.15M | -26.99%861.15M | -8.23%1.08B | -8.23%1.08B | -8.23%1.08B | -0.44%1.18B | -0.44%1.18B | -0.39%1.18B | -0.33%1.18B |
| Surplus reserve funds | 0.00%67.33M | 0.00%67.33M | 0.00%67.33M | 0.00%67.33M | 0.00%67.33M | 0.00%67.33M | 0.00%67.33M | 0.00%67.33M | 0.00%67.33M | 0.00%67.33M |
| Retained profit | 4.01%2.51B | 3.77%2.48B | 2.17%2.45B | 3.34%2.37B | 0.20%2.41B | 5.92%2.39B | 13.28%2.4B | 15.16%2.3B | 25.36%2.41B | 24.39%2.26B |
| Less:Treasury stock | ---- | ---- | ---- | -5.53%224.34M | 20.92%224.34M | 82.25%224.34M | 162.47%323.1M | 92.91%237.47M | 50.72%185.53M | 0.00%123.1M |
| Shareholders equity without minority interests | 2.79%3.56B | 2.61%3.54B | 1.50%3.51B | -0.26%3.43B | -3.69%3.47B | -1.89%3.45B | 2.24%3.45B | 5.61%3.44B | 13.19%3.6B | 14.25%3.51B |
| Total shareholder equity | 2.79%3.56B | 2.61%3.54B | 1.50%3.51B | -0.26%3.43B | -3.69%3.47B | -1.89%3.45B | 2.24%3.45B | 5.61%3.44B | 13.19%3.6B | 14.25%3.51B |
| Total liabilityies and equity | 0.58%3.91B | -0.44%4.01B | -0.34%3.94B | -3.59%3.84B | -7.57%3.88B | -4.32%4.03B | 0.91%3.95B | 4.58%3.98B | 12.03%4.2B | 13.42%4.21B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
In the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US side, indicating that talks could resume i
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm